BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38088813)

  • 1. Investigating the association between asthma and opioid use disorder with interactions of anxiety and depression among a national sample of the US population.
    Qeadan F; McCunn A; Tingey B; Price R; Bobay KL; Saeed AI
    J Asthma; 2024 Jun; 61(6):594-607. PubMed ID: 38088813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Childhood adversity and mental health comorbidity in men and women with opioid use disorders.
    Evans EA; Goff SL; Upchurch DM; Grella CE
    Addict Behav; 2020 Mar; 102():106149. PubMed ID: 31855783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the Association Between Opioid Use Disorder and Alzheimer's Disease and Dementia Among a National Sample of the U.S. Population.
    Qeadan F; McCunn A; Tingey B; Price R; Bobay KL; English K; Madden EF
    J Alzheimers Dis; 2023; 96(1):229-244. PubMed ID: 37742654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preexisting mental health disorders and risk of opioid use disorder in young people: A case-control study.
    Marshall T; Olson K; Youngson E; Abba-Aji A; Li XM; Vohra S; Lewanczuk R
    Early Interv Psychiatry; 2023 Oct; 17(10):963-973. PubMed ID: 36792950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in prescription opioid use and dose trajectories before opioid use disorder or overdose in US adults from 2006 to 2016: A cross-sectional study.
    Wei YJ; Chen C; Fillingim R; Schmidt SO; Winterstein AG
    PLoS Med; 2019 Nov; 16(11):e1002941. PubMed ID: 31689302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between Medication Assisted Therapy Services Delivery and Mortality in a National Cohort of Veterans with Posttraumatic Stress Disorder and Opioid Use Disorder.
    Riblet NB; Gottlieb DJ; Shiner B; Cornelius SL; Watts BV
    J Dual Diagn; 2020; 16(2):228-238. PubMed ID: 31852392
    [No Abstract]   [Full Text] [Related]  

  • 7. COVID-19 complications among patients with opioid use disorder: a retrospective cohort study across five major NYC hospital systems.
    Krawczyk N; Rivera BD; Basaraba C; Corbeil T; Allen B; Schultebraucks K; Henry BF; Pincus HA; Levin FR; Martinez D
    Addiction; 2023 May; 118(5):857-869. PubMed ID: 36459420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration.
    Lin LA; Bohnert ASB; Blow FC; Gordon AJ; Ignacio RV; Kim HM; Ilgen MA
    Addiction; 2021 Jan; 116(1):96-104. PubMed ID: 32428386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discontinuation and tapering of prescribed opioids and risk of overdose among people on long-term opioid therapy for pain with and without opioid use disorder in British Columbia, Canada: A retrospective cohort study.
    Kennedy MC; Crabtree A; Nolan S; Mok WY; Cui Z; Chong M; Slaunwhite A; Ti L
    PLoS Med; 2022 Dec; 19(12):e1004123. PubMed ID: 36454732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and Outcomes of Opioid Use Disorder in Pediatric Surgical Patients: A Retrospective Cohort Study.
    Alalade E; Mpody C; Owusu-Bediako E; Tobias J; Nafiu OO
    Anesth Analg; 2023 Feb; 136(2):308-316. PubMed ID: 35426848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in opioid use disorder and overdose among opioid-naive individuals receiving an opioid prescription in Massachusetts from 2011 to 2014.
    Burke LG; Zhou X; Boyle KL; Orav EJ; Bernson D; Hood ME; Land T; Bharel M; Frakt AB
    Addiction; 2020 Mar; 115(3):493-504. PubMed ID: 31691390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid Use Disorder Increases 30-Day Readmission Risk in Inflammatory Bowel Disease Hospitalizations: a Nationwide Matched Analysis.
    Charilaou P; Mohapatra S; Joshi T; Devani K; Gadiparthi C; Pitchumoni CS; Goldstein D
    J Crohns Colitis; 2020 Jun; 14(5):636-645. PubMed ID: 31804682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adults with Comorbid Posttraumatic Stress Disorder, Alcohol Use Disorder, and Opioid Use Disorder: The Effectiveness of Modified Prolonged Exposure.
    Peck KR; Schumacher JA; Stasiewicz PR; Coffey SF
    J Trauma Stress; 2018 Jun; 31(3):373-382. PubMed ID: 29786898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receipt of medications for opioid use disorder among youth engaged in primary care: data from 6 health systems.
    Bagley SM; Chavez L; Braciszewski JM; Akolsile M; Boudreau DM; Lapham G; Campbell CI; Bart G; Yarborough BJH; Samet JH; Saxon AJ; Rossom RC; Binswanger IA; Murphy MT; Glass JE; Bradley KA;
    Addict Sci Clin Pract; 2021 Jul; 16(1):46. PubMed ID: 34233750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population.
    Morgan JR; Schackman BR; Leff JA; Linas BP; Walley AY
    J Subst Abuse Treat; 2018 Feb; 85():90-96. PubMed ID: 28733097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral health treatment utilization among individuals with co-occurring opioid use disorder and mental illness: Evidence from a national survey.
    Novak P; Feder KA; Ali MM; Chen J
    J Subst Abuse Treat; 2019 Mar; 98():47-52. PubMed ID: 30665603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double trouble: Psychiatric comorbidity and opioid addiction-all-cause and cause-specific mortality.
    Bogdanowicz KM; Stewart R; Broadbent M; Hatch SL; Hotopf M; Strang J; Hayes RD
    Drug Alcohol Depend; 2015 Mar; 148():85-92. PubMed ID: 25578253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of post-traumatic stress disorder on the risk of developing prescription opioid use disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions III.
    Hassan AN; Le Foll B; Imtiaz S; Rehm J
    Drug Alcohol Depend; 2017 Oct; 179():260-266. PubMed ID: 28818717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of OPRM1 Functional Coding Variant With Opioid Use Disorder: A Genome-Wide Association Study.
    Zhou H; Rentsch CT; Cheng Z; Kember RL; Nunez YZ; Sherva RM; Tate JP; Dao C; Xu K; Polimanti R; Farrer LA; Justice AC; Kranzler HR; Gelernter J;
    JAMA Psychiatry; 2020 Oct; 77(10):1072-1080. PubMed ID: 32492095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posttraumatic stress disorder and chronic pain are associated with opioid use disorder: Results from a 2012-2013 American nationally representative survey.
    Bilevicius E; Sommer JL; Asmundson GJG; El-Gabalawy R
    Drug Alcohol Depend; 2018 Jul; 188():119-125. PubMed ID: 29775955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.